Industry Research Reports
Home > Reports > Medical Devices & Consumables > Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 82 Pages
Report ld: 3481481
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Injectable Implant Urinary Incontinence Device Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 185
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 131 million
Market Forecast in 2031(Value)
US$ 185 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Injectable Implant Urinary Incontinence Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Injectable Implant Urinary Incontinence Device by region & country, by Type, and by Application.
The Injectable Implant Urinary Incontinence Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Implant Urinary Incontinence Device.
MARKET SEGMENTATION
By Company
- Boston Scientific
- Laborie Medical
- Urogyn B.V.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Stress Incontinence
- Urge Incontinence
- Overflow Incontinence
- Functional Incontinence
- Others
Segment by Application
- Hospitals and Clinics
- Ambulatory Surgery Centres
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Injectable Implant Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Injectable Implant Urinary Incontinence Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Injectable Implant Urinary Incontinence Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Injectable Implant Urinary Incontinence Device Product Introduction
1.2 Global Injectable Implant Urinary Incontinence Device Market Size Forecast
1.2.1 Global Injectable Implant Urinary Incontinence Device Sales Value (2020-2031)
1.2.2 Global Injectable Implant Urinary Incontinence Device Sales Volume (2020-2031)
1.2.3 Global Injectable Implant Urinary Incontinence Device Sales Price (2020-2031)
1.3 Injectable Implant Urinary Incontinence Device Market Trends & Drivers
1.3.1 Injectable Implant Urinary Incontinence Device Industry Trends
1.3.2 Injectable Implant Urinary Incontinence Device Market Drivers & Opportunity
1.3.3 Injectable Implant Urinary Incontinence Device Market Challenges
1.3.4 Injectable Implant Urinary Incontinence Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Injectable Implant Urinary Incontinence Device Players Revenue Ranking (2024)
2.2 Global Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025)
2.3 Global Injectable Implant Urinary Incontinence Device Players Sales Volume Ranking (2024)
2.4 Global Injectable Implant Urinary Incontinence Device Sales Volume by Company Players (2020-2025)
2.5 Global Injectable Implant Urinary Incontinence Device Average Price by Company (2020-2025)
2.6 Key Manufacturers Injectable Implant Urinary Incontinence Device Manufacturing Base and Headquarters
2.7 Key Manufacturers Injectable Implant Urinary Incontinence Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Injectable Implant Urinary Incontinence Device
2.9 Injectable Implant Urinary Incontinence Device Market Competitive Analysis
2.9.1 Injectable Implant Urinary Incontinence Device Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Injectable Implant Urinary Incontinence Device Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stress Incontinence
3.1.2 Urge Incontinence
3.1.3 Overflow Incontinence
3.1.4 Functional Incontinence
3.1.5 Others
3.2 Global Injectable Implant Urinary Incontinence Device Sales Value by Type
3.2.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Injectable Implant Urinary Incontinence Device Sales Value, by Type (2020-2031)
3.2.3 Global Injectable Implant Urinary Incontinence Device Sales Value, by Type (%) (2020-2031)
3.3 Global Injectable Implant Urinary Incontinence Device Sales Volume by Type
3.3.1 Global Injectable Implant Urinary Incontinence Device Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Type (2020-2031)
3.3.3 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Type (%) (2020-2031)
3.4 Global Injectable Implant Urinary Incontinence Device Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Ambulatory Surgery Centres
4.1.3 Others
4.2 Global Injectable Implant Urinary Incontinence Device Sales Value by Application
4.2.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Injectable Implant Urinary Incontinence Device Sales Value, by Application (2020-2031)
4.2.3 Global Injectable Implant Urinary Incontinence Device Sales Value, by Application (%) (2020-2031)
4.3 Global Injectable Implant Urinary Incontinence Device Sales Volume by Application
4.3.1 Global Injectable Implant Urinary Incontinence Device Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Application (2020-2031)
4.3.3 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Application (%) (2020-2031)
4.4 Global Injectable Implant Urinary Incontinence Device Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Region
5.1.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2020-2025)
5.1.3 Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2026-2031)
5.1.4 Global Injectable Implant Urinary Incontinence Device Sales Value by Region (%), (2020-2031)
5.2 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region
5.2.1 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2020-2025)
5.2.3 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2026-2031)
5.2.4 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (%), (2020-2031)
5.3 Global Injectable Implant Urinary Incontinence Device Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
5.4.2 North America Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
5.5.2 Europe Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
5.6.2 Asia Pacific Injectable Implant Urinary Incontinence Device Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
5.7.2 South America Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
5.8.2 Middle East & Africa Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value
6.2.1 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.2.2 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.3.2 United States Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.4.2 Europe Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.5.2 China Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.5.3 China Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.6.2 Japan Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.7.2 South Korea Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.8.2 Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Injectable Implant Urinary Incontinence Device Sales Value, 2020-2031
6.9.2 India Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.9.3 India Injectable Implant Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Injectable Implant Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Boston Scientific Injectable Implant Urinary Incontinence Device Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Laborie Medical
7.2.1 Laborie Medical Company Information
7.2.2 Laborie Medical Introduction and Business Overview
7.2.3 Laborie Medical Injectable Implant Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Laborie Medical Injectable Implant Urinary Incontinence Device Product Offerings
7.2.5 Laborie Medical Recent Development
7.3 Urogyn B.V.
7.3.1 Urogyn B.V. Company Information
7.3.2 Urogyn B.V. Introduction and Business Overview
7.3.3 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Urogyn B.V. Injectable Implant Urinary Incontinence Device Product Offerings
7.3.5 Urogyn B.V. Recent Development
8 Industry Chain Analysis
8.1 Injectable Implant Urinary Incontinence Device Industrial Chain
8.2 Injectable Implant Urinary Incontinence Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Injectable Implant Urinary Incontinence Device Sales Model
8.5.2 Sales Channel
8.5.3 Injectable Implant Urinary Incontinence Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Injectable Implant Urinary Incontinence Device Market Trends
Table 2. Injectable Implant Urinary Incontinence Device Market Drivers & Opportunity
Table 3. Injectable Implant Urinary Incontinence Device Market Challenges
Table 4. Injectable Implant Urinary Incontinence Device Market Restraints
Table 5. Global Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Company (2020-2025)
Table 7. Global Injectable Implant Urinary Incontinence Device Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Injectable Implant Urinary Incontinence Device Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Injectable Implant Urinary Incontinence Device Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Injectable Implant Urinary Incontinence Device Manufacturing Base and Headquarters
Table 11. Key Manufacturers Injectable Implant Urinary Incontinence Device Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Injectable Implant Urinary Incontinence Device
Table 13. Global Injectable Implant Urinary Incontinence Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Implant Urinary Incontinence Device Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Injectable Implant Urinary Incontinence Device Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Injectable Implant Urinary Incontinence Device Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Value by Type (2020-2025)
Table 20. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Value by Type (2026-2031)
Table 21. Global Injectable Implant Urinary Incontinence Device Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Injectable Implant Urinary Incontinence Device Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Injectable Implant Urinary Incontinence Device Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Injectable Implant Urinary Incontinence Device Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Injectable Implant Urinary Incontinence Device Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Injectable Implant Urinary Incontinence Device Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Injectable Implant Urinary Incontinence Device Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Injectable Implant Urinary Incontinence Device Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Value by Application (2020-2025)
Table 32. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Value by Application (2026-2031)
Table 33. Global Injectable Implant Urinary Incontinence Device Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Injectable Implant Urinary Incontinence Device Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Injectable Implant Urinary Incontinence Device Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Injectable Implant Urinary Incontinence Device Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Injectable Implant Urinary Incontinence Device Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Injectable Implant Urinary Incontinence Device Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Injectable Implant Urinary Incontinence Device Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2020-2025) & (%)
Table 44. Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2026-2031) & (%)
Table 45. Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2020-2025) & (%)
Table 49. Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2026-2031) & (%)
Table 50. Global Injectable Implant Urinary Incontinence Device Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Injectable Implant Urinary Incontinence Device Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Volume, (2026-2031) & (K Units)
Table 57. Boston Scientific Company Information
Table 58. Boston Scientific Introduction and Business Overview
Table 59. Boston Scientific Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Boston Scientific Injectable Implant Urinary Incontinence Device Product Offerings
Table 61. Boston Scientific Recent Development
Table 62. Laborie Medical Company Information
Table 63. Laborie Medical Introduction and Business Overview
Table 64. Laborie Medical Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Laborie Medical Injectable Implant Urinary Incontinence Device Product Offerings
Table 66. Laborie Medical Recent Development
Table 67. Urogyn B.V. Company Information
Table 68. Urogyn B.V. Introduction and Business Overview
Table 69. Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Urogyn B.V. Injectable Implant Urinary Incontinence Device Product Offerings
Table 71. Urogyn B.V. Recent Development
Table 72. Key Raw Materials Lists
Table 73. Raw Materials Key Suppliers Lists
Table 74. Injectable Implant Urinary Incontinence Device Downstream Customers
Table 75. Injectable Implant Urinary Incontinence Device Distributors List
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Implant Urinary Incontinence Device Product Picture
Figure 2. Global Injectable Implant Urinary Incontinence Device Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Injectable Implant Urinary Incontinence Device Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Injectable Implant Urinary Incontinence Device Sales Volume (2020-2031) & (K Units)
Figure 5. Global Injectable Implant Urinary Incontinence Device Sales Price (2020-2031) & (US$/Unit)
Figure 6. Injectable Implant Urinary Incontinence Device Report Years Considered
Figure 7. Global Injectable Implant Urinary Incontinence Device Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Injectable Implant Urinary Incontinence Device Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Injectable Implant Urinary Incontinence Device Revenue in 2024
Figure 10. Injectable Implant Urinary Incontinence Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Stress Incontinence Picture
Figure 12. Urge Incontinence Picture
Figure 13. Overflow Incontinence Picture
Figure 14. Functional Incontinence Picture
Figure 15. Others Picture
Figure 16. Global Injectable Implant Urinary Incontinence Device Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Injectable Implant Urinary Incontinence Device Sales Value Market Share by Type, 2024 & 2031
Figure 18. Global Injectable Implant Urinary Incontinence Device Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 19. Global Injectable Implant Urinary Incontinence Device Sales Volume Market Share by Type, 2024 & 2031
Figure 20. Global Injectable Implant Urinary Incontinence Device Price by Type (2020-2031) & (US$/Unit)
Figure 21. Product Picture of Hospitals and Clinics
Figure 22. Product Picture of Ambulatory Surgery Centres
Figure 23. Product Picture of Others
Figure 24. Global Injectable Implant Urinary Incontinence Device Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 25. Global Injectable Implant Urinary Incontinence Device Sales Value Market Share by Application, 2024 & 2031
Figure 26. Global Injectable Implant Urinary Incontinence Device Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 27. Global Injectable Implant Urinary Incontinence Device Sales Volume Market Share by Application, 2024 & 2031
Figure 28. Global Injectable Implant Urinary Incontinence Device Price by Application (2020-2031) & (US$/Unit)
Figure 29. North America Injectable Implant Urinary Incontinence Device Sales Value (2020-2031) & (US$ Million)
Figure 30. North America Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
Figure 31. Europe Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
Figure 33. Asia Pacific Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Injectable Implant Urinary Incontinence Device Sales Value by Region (%), 2024 VS 2031
Figure 35. South America Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 36. South America Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
Figure 37. Middle East & Africa Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 38. Middle East & Africa Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
Figure 39. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value (%), (2020-2031)
Figure 40. Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Volume (%), (2020-2031)
Figure 41. United States Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 42. United States Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 43. United States Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 44. Europe Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 46. Europe Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 47. China Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 48. China Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 49. China Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 50. Japan Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 51. Japan Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 52. Japan Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 53. South Korea Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 54. South Korea Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 55. South Korea Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 56. Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 57. Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 58. Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 59. India Injectable Implant Urinary Incontinence Device Sales Value, (2020-2031) & (US$ Million)
Figure 60. India Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
Figure 61. India Injectable Implant Urinary Incontinence Device Sales Value by Application (%), 2024 VS 2031
Figure 62. Injectable Implant Urinary Incontinence Device Industrial Chain
Figure 63. Injectable Implant Urinary Incontinence Device Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Injectable Implant Urinary Incontinence Device market?
What is the annual compound growth rate of the global Injectable Implant Urinary Incontinence Device market size from 2025 to 2031?
What was the global market size of Injectable Implant Urinary Incontinence Device in 2031?
What was the global market size of Injectable Implant Urinary Incontinence Device in 2025?
Related Reports
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 121
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 104
USD 2900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 67
USD 4250.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 118
USD 4900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2025
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 67
USD 2900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-04-12
Pages: 75
USD 4900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-17
Pages: 74
USD 2900.00
(Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-10
Pages: 82
USD 3950.00
(Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 121
USD 3950.00 (Single User License)Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 104
USD 2900.00 (Single User License)Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 67
USD 4250.00 (Single User License)Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 118
USD 4900.00 (Single User License)Global Injectable Implant Urinary Incontinence Device Market Research Report 2025
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 67
USD 2900.00 (Single User License)Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-04-12
Pages: 75
USD 4900.00 (Single User License)Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-17
Pages: 74
USD 2900.00 (Single User License)Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-10
Pages: 82
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now